✦ LIBER ✦

An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects

✍ Scribed by Shin, Kwang-Hee; Lim, Kyoung Soo; Lee, Howard; Jang, In-Jin; Yu, Kyung-Sang

Book ID: 125358929
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 293 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-014-0068-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship Between Absolute Neutrophil

Relationship Between Absolute Neutrophil Count Profiles and Pharmacokinetics of DA-3031, a Pegylated Granulocyte Colony-Stimulating Factor (Pegylated-G-CSF): A Dose Block-Randomized, Double-Blind, Dose-Escalation Study in Healthy Subjects

✍ Ahn, Li Young; Shin, Kwang-Hee; Lim, Kyoung Soo; Kim, Tae-Eun; Jeon, Hyewon; Yoo 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 430 KB

Evidence that the granulocyte colony-sti

Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model

✍ Anne C Kotto-Kome; Samuel E Fox; Wenge Lu; Bing-Bing Yang; Robert D Christensen; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Pharmacokinetic and pharmacodynamic mode

Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats

✍ M. Scholz; C. Engel; D. Apt; S. L. Sankar; E. Goldstein; M. Loeffler 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 915 KB

Ragaglitazar: The Pharmacokinetics, Phar

Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes

✍ Skrumsager, B. K.; Nielsen, K. K.; Müller, M.; Pabst, G.; Drake, P. G.; Edsberg, 📂 Article 📅 2003 🏛 Sage Publications 🌐 English ⚖ 193 KB

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol for a controlled clinical trial developed by consensus of an international study group¶ Part two: design of the study

✍ A. Bauhofer; W. Lorenz; B. Stinner; M. Rothmund; M. Koller; H. Sitter; I. Celik; 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 242 KB

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol of a controlled clinical trial developed by consensus of an international study group¶ Part three: individual patient, complication algorithm and quality management¶

✍ B. Stinner; A. Bauhofer; W. Lorenz; M. Rothmund; U. Plaul; A. Torossian; I. Celi 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 218 KB